156 related articles for article (PubMed ID: 17436139)
21. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.
Bertolini F; Chiara S; Bengala C; Antognoni P; Dealis C; Zironi S; Malavasi N; Scolaro T; Depenni R; Jovic G; Sonaglio C; Rossi A; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):466-72. PubMed ID: 19004567
[TBL] [Abstract][Full Text] [Related]
23. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.
Everaert H; Hoorens A; Vanhove C; Sermeus A; Ceulemans G; Engels B; Vermeersch M; Verellen D; Urbain D; Storme G; De Ridder M
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):91-6. PubMed ID: 20605358
[TBL] [Abstract][Full Text] [Related]
24. Relationship between of short-course preoperative radiotherapy and serum albumin level and postoperative complications in rectal cancer surgery.
Trifunović B; Kršić J; Bezmarević M; Grbović D; Zeljković D; Nešković B; Soldatović I; Prelević R; Mirković D
Vojnosanit Pregl; 2015 Aug; 72(8):663-9. PubMed ID: 26495691
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
[TBL] [Abstract][Full Text] [Related]
26. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.
Francois Y; Nemoz CJ; Baulieux J; Vignal J; Grandjean JP; Partensky C; Souquet JC; Adeleine P; Gerard JP
J Clin Oncol; 1999 Aug; 17(8):2396. PubMed ID: 10561302
[TBL] [Abstract][Full Text] [Related]
27. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.
Hesselager C; Vuong T; Påhlman L; Richard C; Liberman S; Letellier F; Folkesson J
Colorectal Dis; 2013 Jun; 15(6):662-6. PubMed ID: 23461819
[TBL] [Abstract][Full Text] [Related]
28. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
[TBL] [Abstract][Full Text] [Related]
29. Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group.
Hospers GA; Punt CJ; Tesselaar ME; Cats A; Havenga K; Leer JW; Marijnen CA; Jansen EP; Van Krieken HH; Wiggers T; Van de Velde CJ; Mulder NH
Ann Surg Oncol; 2007 Oct; 14(10):2773-9. PubMed ID: 17653805
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment Tumor Thickness as a Predictor of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy for Stage II/III Rectal Adenocarcinoma.
Xu B; Chen Y; Guo Y; Zhou D; Yue Z; Duan Q; Yang Y; Guan G; Chi P; Lin C
Am J Clin Oncol; 2018 Jun; 41(6):601-606. PubMed ID: 27672742
[TBL] [Abstract][Full Text] [Related]
31. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.
Caravatta L; Padula GD; Picardi V; Macchia G; Deodato F; Massaccesi M; Sofo L; Pacelli F; Rotondi F; Cecere G; Sallustio G; Di Lullo L; Piscopo A; Mignogna S; Bonomo P; Cellini N; Valentini V; Morganti AG
Acta Oncol; 2011 Nov; 50(8):1151-7. PubMed ID: 21851185
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
[TBL] [Abstract][Full Text] [Related]
33. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.
Medich D; McGinty J; Parda D; Karlovits S; Davis C; Caushaj P; Lembersky B
Dis Colon Rectum; 2001 Aug; 44(8):1123-8. PubMed ID: 11535851
[TBL] [Abstract][Full Text] [Related]
34. Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders.
Rengan R; Paty PB; Wong WD; Guillem JG; Weiser M; Temple L; Saltz L; Minsky BD
Clin Colorectal Cancer; 2006 Mar; 5(6):413-21. PubMed ID: 16635280
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancer.
Gasent Blesa JM; Garde Noguera J; Laforga Canales JB; Giner Bosch V; Alberola A; Soler Tortosa M; Peris Godoy M; Sanchez JL; Provencio Pulla M; Alberola Candel V
J Gastrointest Cancer; 2012 Dec; 43(4):553-61. PubMed ID: 22371167
[TBL] [Abstract][Full Text] [Related]
36. A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer.
Willeke F; Horisberger K; Kraus-Tiefenbacher U; Wenz F; Leitner A; Hochhaus A; Grobholz R; Willer A; Kähler G; Post S; Hofheinz RD
Br J Cancer; 2007 Mar; 96(6):912-7. PubMed ID: 17325705
[TBL] [Abstract][Full Text] [Related]
37. Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer.
Adell G; Zhang H; Jansson A; Sun XF; Stål O; Nordenskjöld B
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):659-63. PubMed ID: 11395233
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression.
Eich HT; Stepien A; Zimmermann C; Hellmich M; Metzger R; Hölscher A; Müller RP
Strahlenther Onkol; 2011 Apr; 187(4):225-30. PubMed ID: 21424305
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
40. Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II).
Widder J; Herbst F; Dobrowsky W; Schmid R; Pokrajac B; Jech B; Chiari C; Stift A; Maier A; Karner-Hanusch J; Teleky B; Wrba F; Jakesz R; Poetter R
Br J Cancer; 2005 Apr; 92(7):1209-14. PubMed ID: 15785745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
